RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+16.36%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.73B
AUM Growth
+$1.73B
(+16%)
Cap. Flow
+$54.9M
Cap. Flow
% of AUM
3.17%
Top 10 Holdings %
Top 10 Hldgs %
27.21%
Holding
142
New
9
Increased
33
Reduced
17
Closed
2
Top Buys
| 1 |
Humana
HUM
|
$27.3M |
| 2 |
Johnson & Johnson
JNJ
|
$21.8M |
| 3 |
Pacira BioSciences
PCRX
|
$13.1M |
| 4 |
AFAM
Almost Family Inc
AFAM
|
$10.9M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$10.3M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$28.2M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$21.3M |
| 3 |
Aclaris Therapeutics
ACRS
|
$12.7M |
| 4 |
Medpace
MEDP
|
$4.87M |
| 5 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$3.19M |
Sector Composition
| 1 | Healthcare | 82.21% |
| 2 | Financials | 2.45% |
| 3 | Consumer Discretionary | 0.63% |
| 4 | Industrials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Theravance Biopharma
TBPH
$699M
| $22.1M | 1.27% | 600,000 | – | – |
|
|
27
Johnson & Johnson
JNJ
$427B
| $21.8M | 1.26% | +175,000 | New | +$21.8M |
|
|
WMGI
28
DELISTED
Wright Medical Group Inc
WMGI
| $20.9M | 1.2% | 670,000 +3,000 | +0.4% | +$93.4K |
|
|
29
Aclaris Therapeutics
ACRS
$209M
| $20.1M | 1.16% | 675,000 -425,000 | -39% | -$12.7M |
|
30
Gilead Sciences
GILD
$140B
| $19.5M | 1.12% | 286,500 +10,000 | +4% | +$679K |
|
31
Galapagos
GLPG
$2.07B
| $18.1M | 1.04% | 210,000 | – | – |
|
32
Jazz Pharmaceuticals
JAZZ
$7.75B
| $18M | 1.04% | 123,700 | – | – |
|
33
Neurocrine Biosciences
NBIX
$13.8B
| $17.8M | 1.02% | 410,000 | – | – |
|
34
Prothena Corp
PRTA
$441M
| $17.3M | 1% | 309,500 | – | – |
|
35
Collegium Pharmaceutical
COLL
$1.22B
| $17.1M | 0.99% | 1,700,000 +100,000 | +6% | +$1.01M |
|
|
RARX
36
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $16.8M | 0.97% | 788,959 -37,041 | -4% | -$789K |
|
37
Amgen
AMGN
$155B
| $16.1M | 0.93% | 98,000 +1,500 | +2% | +$246K |
|
|
AMRN
38
Amarin Corp
AMRN
$311M
| $16M | 0.92% | 5,001,200 +9,700 | +0.2% | +$31K |
|
39
Hologic
HOLX
$14.9B
| $14.5M | 0.83% | 340,000 +75,000 | +28% | +$3.19M |
|
40
Willis Towers Watson
WTW
$31.9B
| $14.4M | 0.83% | 110,000 | – | – |
|
41
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $14.3M | 0.82% | 675,000 +190,500 | +39% | +$4.03M |
|
42
Danaher
DHR
$147B
| $13.7M | 0.79% | 160,000 | – | – |
|
43
Edwards Lifesciences
EW
$47.8B
| $13.4M | 0.77% | 142,500 +22,000 | +18% | +$2.07M |
|
|
WBA
44
DELISTED
Walgreens Boots Alliance
WBA
| $13.4M | 0.77% | 161,000 | – | – |
|
|
NVTA
45
DELISTED
Invitae Corporation
NVTA
| $13.3M | 0.77% | 1,200,000 | – | – |
|
|
DERM
46
DELISTED
Dermira, Inc.
DERM
| $13.2M | 0.76% | 387,600 +25,000 | +7% | +$853K |
|
47
Biogen
BIIB
$19.4B
| $13.1M | 0.76% | 48,000 +1,000 | +2% | +$273K |
|
|
CLVS
48
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.7M | 0.68% | 184,500 +74,500 | +68% | +$4.74M |
|
49
TherapeuticsMD
TXMD
$12.8M
| $11.5M | 0.66% | 1,600,000 -120,000 | -7% | -$864K |
|
50
Encompass Health
EHC
$12.3B
| $11.3M | 0.65% | 265,000 | – | – |
|